SMMT — AI Stock Analysis & Recommendation
TradeFlare's AI research teams rate SMMT a BUY with a conviction of 45/100. The current price is $17.28.
- Entry: $17.28
- Target: $20.74
- Stop: $14.69
The post-earnings drift signal suggests a multi-week trend. Catalysts to watch: Positive clinical trial data for lead drug ivonescimab; Analyst consensus strongly 'buy' with a high mean target price; Post-earnings gap and drift signal indicating potential continued upward momentum. Key risks: High operating cash burn rate and potential for future dilution; Heavy reliance on the success of its lead drug candidate, ivonescimab; High realized volatility and potential for deep drawdowns.
FlareScore breakdown — Technical: 70 · Fundamental: 60 · Sentiment: 75 · Risk: 10
Frequently asked questions
Is SMMT a buy? TradeFlare's AI currently rates SMMT a BUY with 45/100 conviction.
What is the price target for SMMT? TradeFlare's AI price target for SMMT is $20.74.
Last updated September 09, 2026 · AI-generated analysis for informational purposes, not financial advice.